Dr. Richard Fine, one of our exceptional breast surgeons, is actively involved in groundbreaking research shaping the future of breast cancer care.
An FDA panel has endorsed the use of the ProSense cryoablation system as a less-invasive alternative to surgery for some early-stage, low-risk breast cancer patients. This technology uses extreme cold to destroy tumors, offering hope for patients seeking effective and less-invasive treatment options.
While some questions still remain regarding recurrence rates and patient eligibility, Dr. Fine and his colleagues are committed to ensuring thorough research and informed decisions for our patients.